The ETERNAL Horizon Europe Research and Innovation Action has just made seven industrial case study summaries publically available. The easily-read two-page documents provide a concise summary of the key features, progress to date, and further steps involved as several of the project's applied research efforts start to yield fruit in an at or near industrial ready state.

This video describes how concerted efforts in ETERNAL's case studies distributed across a range of industrial use cases and the extended value chain for pharmaceuticals are making a real and positive impact upon the future sustainability and competitiveness of the sector.

Artificial Intelligence (AI) and Big Data (BD) presents an unprecedented opportunity within the framework outlined by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) to enhance quality assurance, streamline drug development processes, increase traceability at supply chain level, and ultimately improve quality and safety of medicinal products. A new report generated by the ETERNAL Research and Innovation Action discusses the ethical considerations and legislative imperatives for integrating AI and BD within the ICH guidelines to ensure responsible usage and sustainable business outcomes.